October 20, 2021

Treating sickle cell anemia with the drug hydroxyurea may also reverse related heart abnormalities, a new study suggests. Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax heart muscles, a condition called diastolic dysfunction that can lead to heart disease and...

Although the clinical efficacy of anti-VEGF treatments for wet age-related macular degeneration has been established, real-life results may differ, particularly due to the difficulty of managing treatment over time. This retrospective cohort study, published in BMC Ophthalmology, describes and analyzes real-life data from patients treated with anti-VEGFs, and compares them to data from previous clinical trials...

The gold standard treatment for wet age-related macular degeneration (AMD) involves repeated administration of anti-VEGF intravitreal injections. Unfortunately, due to the ongoing COVID-19 pandemic, many patients worldwide have been unable to receive treatment due to lockdowns or other measures and restrictions. This study, published in Ophthalmology and Therapy, focuses on the effects of delayed treatment of...